Northwest Biotherapeutics (NWBT) to Ring the NASDAQ Stock Market Opening Bell  
12/17/2012 9:20:14 AM

ADVISORY, Dec. 17, 2012 (GLOBE NEWSWIRE) -- What: Northwest Biotherapeutics, Inc. [NWBO], a biotechnology company focused on developing immunotherapy products to treat cancers more effectively and without toxicity, now in Phase III clinical trials, will visit the NASDAQ MarketSite in Times Square.